Navigation Links
Vivo Ventures Announces Promotions of Dr. Chen Yu and Dr. James Zhao to Managing Partner
Date:5/25/2011

PALO ALTO, Calif., May 25, 2011 /PRNewswire/ -- Vivo Ventures, LLC (“Vivo”) announced today the promotions of Dr. Chen Yu and Dr. James Zhao to Managing Partner in recognition of their contributions to the firm.

Dr. Yu first joined Vivo in 2004 and has been a Partner since 2007.   He currently serves as a Director of Sagent Pharmaceuticals, Nora Therapeutics and Synaptic International, and has been actively involved in many of the firm’s earlier private and public investments, including China KangHui Holdings, Achillion, Transcept, Tranzyme and Cubist.  In addition, he has had an operational role in a part-time capacity as Chief Business Officer of China KangHui Holdings overseeing their corporate development and investor relations efforts.  Prior to his time at Vivo, Dr. Yu was an early employee at aQuantive, which listed on Nasdaq in 2000 and ultimately was acquired for $6.5B by Microsoft.  Dr. Yu also currently serves on the Board of Governors for the Stanford Medical School Alumni Association.  Dr. Yu received his B.A. from Harvard University; his M.D. and MBA degrees are both from Stanford.

Dr. Zhao first began working with the firm in late 2005.  With his promotion to Managing Partner, he will now be heading Vivo’s China team.  He has made significant contributions to the firm’s success in China, including opening its Shanghai and Chengdu offices.  He was also instrumental in assisting in the formation of Vivo’s RMB denominated fund in partnership with the Chengdu Hi Tech Yinke Fund.  Dr. Zhao is actively involved in all of Vivo’s investments in China and will serve as the lead Vivo representative for Shanghai Hile, Sundise, and IMH.  Prior to joining Vivo, Dr. Zhao was a consultant with the Monitor Group focusing on life sciences.  Prior to that, he worked as a sales supervisor for Bristol Myers Squibb in Chengdu.  Dr. Zhao received his medic
'/>"/>

SOURCE Vivo Ventures, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. XDATA Retains Adapt IP Ventures to Market Patents and Technology for Automated 3D Ultrasound Imaging System
2. Aethlon Medical to Present the Aethlon ADAPT™ System at C21 BioVentures™ Life Sciences Partnering Conference
3. JumpStart Ventures Invests in Cleveland-based SPR Therapeutics
4. MEDomics Announces a Growth Capital Investment from SpaGus Ventures LLC and Gary Augusta Joins MEDomics as Chief Operating Officer
5. JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics
6. Leader Ventures Supports Innovative Drug Discovery Company Carmot
7. PharmaVentures Appoints Paul Phull as Senior Director
8. SI-BONE, Inc. Closes $11.0 Million Financing Led by Skyline Ventures
9. JumpStart Ventures Invests In and Provides Entrepreneurial Assistance to Drug Development Company
10. Sangon & Bio Basic Inc. Closes $10 Million Round of Investment by Qiming Ventures
11. BIO Ventures for Global Health Opens San Francisco Office; Hires New Senior Staff
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... British Columbia, March 26, 2015  OncoGenex Pharmaceuticals, ... summary of clinical developments and announced fourth quarter ... Clinical Developments and Anticipated Near-term MilestonesCustirsen ... Teva agreed to negotiate the termination of their ... of the final termination agreement are ongoing. ...
(Date:3/26/2015)... 2015 Over-the-counter healthcare costs can be ... a new survey of store brand over-the-counter products ... cold to diabetes, can offer significant savings for ... the Private Label Manufacturers Association, assembled a market ... those essential for treatment of pre-diabetes and diabetes. ...
(Date:3/26/2015)... PLEASANTON, Calif. , March 26, 2015  Desert ... the Nation five times , is the first ... System in its emergency department to help clinicians prevent ... in Victorville, Calif. , is a ... and bariatric patients.  Using the Leaf Patient Monitor in ...
Breaking Medicine Technology:OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8Consumers can keep over-the-counter medicine affordable by using store brands 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3
... , ATLANTA and STOCKHOLM , ... (1907-1986), inventor of the radiosurgical instrument that bears his ... (Solna, Sweden ), performed the world,s first ... location of the first Leksell Gamma Knife. Karolinska University ...
... April 23 Yesterday, T he Lancet ... once-daily human GLP-1 analog, Victoza® (liraglutide [rDNA] injection) with a DPP-4 ... reductions in A1C, fasting plasma glucose (FPG), and body weight than ... , , ...
Cached Medicine Technology:Karolinska University Hospital Acquires Leksell Gamma Knife Perfexion to Expand Radiosurgery Versatility, Efficiency in Brain Cancer Therapy 2Karolinska University Hospital Acquires Leksell Gamma Knife Perfexion to Expand Radiosurgery Versatility, Efficiency in Brain Cancer Therapy 3The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 2The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 3The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 4The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 5The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 6
(Date:3/26/2015)... Let’s not lose focus of why people ... traffic magnets. Three out of 4 consumers choose to ... department, according to a Packaged Facts survey. Produce Managers ... to add more fruits and vegetables to their lifestyle. ... April 2. As featured in the Chase’s Calendar of ...
(Date:3/26/2015)... March 26, 2015 UC Davis will ... into the origins of schizophrenia: A Silvio O. Conte ... only 15 such centers in the United States. , ... grant from the National Institutes of Mental Health, which ... novel hypothesis that an origin of schizophrenia may be ...
(Date:3/26/2015)... York, New York (PRWEB) March 26, 2015 ... continue to move forward nationwide, with the issuance ... underway in Pennsylvania and Louisiana. According to an ... federal multidistrict litigation established for Xarelto injury claims ... Louisiana will now allow plaintiffs to file cases ...
(Date:3/26/2015)... DC (PRWEB) March 26, 2015 “The SWEET ... to make healthy options more available and help parents who ... penny tax is a reasonable approach to support public health, ... of this issue for the health of all families,” said ... for Hispanic Health on the introduction of the Sugar-Sweetened Beverage ...
(Date:3/26/2015)... CA (PRWEB) March 26, 2015 Dr. ... are proud to announce expanded offerings for Bay Area ... Francisco Dental Implant Center has long been a top-rated ... expanded its offerings to meet the strong demand by ... our reputation as a top-rated dental implant facility in ...
Breaking Medicine News(10 mins):Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 3Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 4Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3
... WASHINGTON, Oct. 4 Michael J. Fitzpatrick,executive director ... today,thanked Senator Pete Domenici (New Mexico) for his ... statement followed the senator,s,announcement of his intention to ... 35 years in the nation,s capital, Senator Pete ...
... Oct. 4 Biomoda, Inc. (OTC,Bulletin Board: BMOD) ... lung cancer detection testing and other cancer diagnostic ... of,Southborough, Mass. to provide a range of clinical ... clinical programs. "Averion is a global clinical ...
... The Hartford Center for Geriatric Nursing Excellence in the ... Hartford centers in the nation, have been funded for ... have the most recent evidence-based guidelines for caring for ... Centers of Geriatric Nursing Excellence, which will form the ...
... National IPF Awareness Week on Capitol Hill Drives,Efforts ... SAN JOSE, Calif., Oct. 4 The ... success of its fifth,annual National IPF Awareness Week, ... about the critical need to fund new research ...
... N.J., Oct. 4 The following is a,statement regarding ... health information online:, It is encouraging that companies ... personal health record (PHR) products and systems,that people can ... more companies will follow suit. Having ready access to ...
... MedImmune, Inc. today announced results from two important studies ... (IDSA) 45th Annual Meeting adding to the body of ... a viral pathogen that produces annual outbreaks usually between ... in healthy children, it can prove to be a ...
Cached Medicine News:Health News:Biomoda and Averion International Announce Agreement for Clinical Services 2Health News:CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget 2Health News:CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget 3Health News:CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget 4Health News:Statement Regarding Microsoft's Announcement of New Services to Help People Store Their Health Information Online 2Health News:Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: